Differential Vascular and Endocrine Effects of Valsartan/Sacubitril in Heart Failure With Reduced Ejection Fraction
Status:
Completed
Trial end date:
2020-09-05
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate whether valsartan/sacubitril leads to a superior
improvement in endothelial function and endocrine status compared to valsartan alone.